Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      WERFEN RECEIVES US FDA 510(k) CLEARANCE FOR ROTEM® SIGMA COMPLETE CARTRIDGE FOR USE IN TRAUMA

      blue werfen logo png

      News provided by

      Werfen

      Nov 17, 2026, 08:30 ET

      Share this article

      Share this article


      —Extends ROTEM sigma Testing to Trauma, Supporting Rapid Viscoelastic Testing Bleeding Management—

      BEDFORD, Mass., Nov. 17, 2026 /PRNewswire/ -- Werfen today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma. The new indication extends the use of the ROTEM sigma viscoelastic testing system beyond cardiovascular surgery and liver transplantation, enabling bleeding management in the trauma setting within the United States. See full Indications for Use below.

      Continue Reading
      ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma.
      ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma.

      Traumatic injury is responsible for approximately 10% of deaths worldwide, and uncontrolled bleeding remains one of the leading causes of potentially preventable death following severe trauma.1–3 Trauma-induced coagulopathy presents an additional challenge, requiring rapid assessment and timely intervention to support patient management.4 Early evaluation of coagulation status is critical in these time-sensitive situations, and current trauma management guidelines recommend viscoelastic testing as part of a goal-directed approach to bleeding management and coagulation support.5–7

      "Trauma teams are required to make critical treatment decisions within minutes, when every moment matters," said Bill Crandell, Vice President, Commercial Operations, North America at Werfen. "The clearance of the ROTEM sigma  complete cartridge for use in trauma expands access to rapid, actionable coagulation information at the point of care, helping make informed treatment decisions during trauma resuscitation. This milestone underscores our commitment to bleeding management and providing clinicians with innovative tools that support timely, evidence-based care."

      ROTEM sigma is a fully automated viscoelastic testing system that delivers real-time assessment of clot initiation, clot firmness, and clot stability at the point of care. By providing timely information about a patient's coagulation status, the system supports individualized treatment strategies during critical bleeding events. ROTEM sigma results should be interpreted together with the patient's clinical condition and other laboratory tests.

      Designed to simplify testing and streamline workflow, ROTEM sigma incorporates a fully automated cartridge-based system with closed-tube direct sampling, designed to minimize manual handling steps and reduce operator-dependent variability. Additional features of the ROTEM sigma include automated assay initiation, integrated quality control, continuous internal system monitoring, intuitive touchscreen operation, and room-temperature cartridge storage. Reduced operator interaction is designed to simplify implementation across a variety of acute care settings. Large, easy-to-interpret TEMograms and live viewing with GEMweb® Live provide clinicians with real-time visibility into coagulation dynamics.

      Indications for Use
      The ROTEM sigma Thromboelastometry System is a fully integrated and automated in vitro diagnostic system designed to monitor and analyze a patient's coagulation status by measuring the viscoelastic properties of a 3.2% citrated venous or arterial whole blood sample. The ROTEM sigma system is indicated for use with adult patients 21 years and older where a semiquantitative evaluation of their blood coagulation properties is desired, in the point of care and laboratory settings. The ROTEM sigma system is not intended for use in pre-hospital trauma settings.

      Coagulation evaluations on the ROTEM sigma system with ROTEM sigma complete are used to assess peri-operative hemorrhage and/or thrombosis in trauma. Coagulation evaluations on the ROTEM sigma system with ROTEM sigma complete + hep are used to assess peri-operative hemorrhage and/or thrombosis in cardiovascular surgery and liver transplantation.

      The ROTEM sigma system includes the following assays contained in single use, multichannel cartridges; ROTEM sigma complete (INTEM C, EXTEM C, FIBTEM C, APTEM C) and ROTEM sigma complete + hep (INTEM C, EXTEM C, FIBTEM C, HEPTEM C):

      INTEM C is used for the assessment of coagulation via the intrinsic pathway in citrated whole blood samples.

      EXTEM C is used for the assessment of coagulation via the extrinsic pathway in citrated whole blood samples.

      FIBTEM C is used for the assessment of coagulation via the extrinsic pathway in citrated whole blood samples, after blocking platelet contribution to clot firmness.

      HEPTEM C is used for the assessment of coagulation via the intrinsic pathway in citrated whole blood samples, after inactivating heparin.

      APTEM C is used for the assessment of coagulation via the extrinsic pathway in citrated whole blood samples, after blocking fibrinolysis.

      Results from the ROTEM sigma should not be the sole basis for a patient diagnosis; ROTEM sigma results should be considered along with a clinical assessment of the patient's condition and other laboratory tests.

      For in vitro Diagnostoc Use.
      For use by healthcare professionals only. 

      References

      1. World Health Organization. Injuries and Violence: The Facts. World Health Organization; 2010.
      2. Tejada-Vera B, Bastian BA, Miniño AM. Deaths: leading causes for 2024. Natl Vital Stat Rep. 2026;75(7):1-117. doi:10.15620/cdc/252465.
      3. Callcut RA, Kornblith LZ, Conroy AS, et al. The why and how our trauma patients die: A prospective Multicenter Western Trauma Association study. J Trauma Acute Care Surg. 2019;86(5):864-870. doi:10.1097/TA.0000000000002205
      4. Natalini D, Xhemalaj R, Carelli S. Viscoelastic Hemostatic Assays in the Management of Trauma-Induced Coagulopathy: A Clinical Update. J Clin Med. 2025;15(1):12. Published 2025 Dec 19. doi:10.3390/jcm15010012
      5. Bugaev N, Como JJ, Golani G, et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: Practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020;89(6):999-1017. doi:10.1097/TA.0000000000002944
      6. Rotondo MF, Cribari C, Smith R, et al. Resources for Optimal Care of the Injured Patient. American College of Surgeons Committee on Trauma; 2014.
      7. American College of Surgeons Trauma Quality Programs. Best Practices Guidelines for Transfusion in Trauma. American College of Surgeons; 2026. Accessed November 16, 2026. https://www.facs.org/media/4y2arm2q/acs-tqp-best-practices-for-transfusion.pdf

      About Werfen's Acute Care Diagnostics Portfolio
      The ROTEM sigma system is part of Werfen's integrated and comprehensive ACD product portfolio—helping clinicians and laboratorians achieve better patient outcomes, lower total cost of care, assure accreditation compliance and improve operational efficiency in hospital acute care settings. For Whole Blood Hemostasis testing, ROTEM viscoelastic testing systems, the GEM Hemochron™ 100 system, and the VerifyNow™ platelet-reactivity testing system inform key clinical decisions regarding transfusion, bleeding risk and heparin dose adjustment during surgical and interventional procedures along with a clinical assessment of the patient's condition and other laboratory tests. For Blood Gas testing, the GEM Premier systems, including GEM Premier 7000, 5000 and 3500 systems, and the Avoximeter™ 1000 portable CO-Oximeter, simplify POC operations by automating key labor- and skill-intensive tasks, including quality management and system maintenance. Complementing these testing systems, GEMweb Plus 500 Custom Connectivity provides centralized management of analyzers, operators and data, while GEMweb Live consolidates results from connected Werfen systems on a single screen for real-time viewing in the cardiovascular operating room. From Cardiovascular Operating Rooms and Catheterization Labs to Intensive Care Units and Emergency Departments, whole-blood, cartridge-based systems with Werfen's integrated data management solutions, help hospitals improve efficiency and enhance patient care.

      Werfen (www.werfen.com), founded in 1966, is a worldwide developer, manufacturer and distributor of specialized diagnostic instruments, related reagents, automation workcells, and data management solutions for use primarily in hospitals and independent clinical laboratories. The Company's clinical areas of focus include Hemostasis, Acute Care, Transfusion, Autoimmunity, and Transplant.

      Werfen's Acute Care portfolio includes the new GEM Premier 7000 with iQM3, the GEM® Premier™ 5000 with iQM®2, GEM Premier 3500 system with iQM, GEM Premier ChemSTAT™ system, ROTEM® viscoelastic testing systems, Hemochron™ systems, VerifyNow™ platelet function testing system, and Avoximeter™1000 CO-Oximeter, GEMweb® Plus 500 Custom Connectivity and GEMweb Live.

      The Hemostasis portfolio includes ACL TOP® Family 50 Series and ACL TOP Family Hemostasis Testing Systems, ACL AcuStar® system, ACL Elite® systems, HemoCell™ Specialized Lab Automation, HemoHub™ Intelligent Data Manager, along with the comprehensive line of HemosIL® assays.

      The Werfen logo is a trademark of Werfen. GEM, Premier, GEM Premier ChemSTAT, GEMweb, iQM, ChemSTAT, HemosIL, ACL, ACL TOP, ACL Elite, ACL AcuStar, ReadiPlasTin, RecombiPlasTin, SynthASil, SynthAFax, ROTEM, Hemochron, VerifyNow and Avoximeter are trademarks of Instrumentation Laboratory Company, d.b.a Werfen, and/or one of its subsidiaries or parent companies and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners. This press release may contain forward-looking statements, which are subject to risks and uncertainties. Actual results may differ materially.

      SOURCE Werfen

      Modal title

      Also from this source

      Werfen startet im Rahmen seiner Feierlichkeiten zum 60-jährigen Jubiläum eine Kampagne, um Fachkräften im Gesundheitswesen und Laboren zu danken

      Werfen startet im Rahmen seiner Feierlichkeiten zum 60-jährigen Jubiläum eine Kampagne, um Fachkräften im Gesundheitswesen und Laboren zu danken

      Die In-vitro-Diagnostik (IVD) spielt eine entscheidende Rolle bei lebensrettenden klinischen Entscheidungen. Als Zeichen der Wertschätzung und des...

      Werfen lance une campagne de remerciement aux professionnels de santé et aux laboratoires à l'occasion de son 60ᵉ anniversaire

      Werfen lance une campagne de remerciement aux professionnels de santé et aux laboratoires à l'occasion de son 60ᵉ anniversaire

      Le diagnostic in vitro (DIV) joue un rôle crucial dans les décisions cliniques qui sauvent des vies. Pour témoigner de sa reconnaissance et remercier ...

      More Releases From This Source

      Explore

      Medical Equipment

      Medical Equipment

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      FDA Approval

      FDA Approval

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.